ANIX Latest Press Releases

-- October 26, 2026 --

Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial PRNewswire 8:30 AM

-- October 13, 2026 --

Anixa Biosciences' Ovarian Cancer CAR-T Therapy Inventor to Deliver Keynote at Ovarian Cancer Midwest Focus Conference PRNewswire 8:40 AM

-- October 5, 2026 --

Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial PRNewswire 8:16 AM

-- October 1, 2026 --

Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial PRNewswire 8:35 AM

-- September 21, 2026 --

Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040 PRNewswire 8:45 AM

-- September 16, 2026 --

Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board PRNewswire 9:16 AM

-- September 9, 2026 --

Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV PRNewswire 8:35 AM

-- September 3, 2026 --

Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026 PRNewswire 8:00 AM

-- August 24, 2026 --

Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy PRNewswire 8:55 AM

-- August 18, 2026 --

Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference PRNewswire 8:45 AM

-- July 6, 2026 --

Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date PRNewswire 8:30 AM

-- June 29, 2026 --

Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040 PRNewswire 8:46 AM

-- June 26, 2026 --

Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium PRNewswire 9:11 AM

-- June 11, 2026 --

Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium PRNewswire 9:05 AM

Market Data Delayed 15 Minutes